Peter Werth

Peter J.
Werth is the founder of Chemwerth, Inc., founded in 1982, where the title held is Chairman since 2024.
Mr. Werth is also the founder of The Werth Family Foundation, Inc...
Current jobs include Director at Cingulate Therapeutics LLC since 2018, Director at SciDose LLC, Director at Altos Therapeutics LLC since 2012, Director at VM Pharma LLC since 2010, Director at Nuance Designs of CT LLC since 2015, Director at Alzeca Biosciences, Inc. since 2017, Director at MedRhythms, Inc. since 2018, Director at Likarda LLC since 2017, Independent Director at Cingulate Works, Inc. since 2018, Director at VM Oncology LLC since 2014, Director at Perseus Science Group LLC since 2015, Director at Cingulate, Inc. since 2018, Director at Alopexx Vaccines LLC since 2012, Director at Alopexx, Inc., Director at VM Therapeutics LLC since 2012, and Manager at Werth Family Investment Associates LLC.
Former jobs include Director at InnoPharma, Inc., Research & Development Officer at Pfizer Inc. from 1975 to 1975, and Vice President-Sales & Marketing at Ganes Chemicals, Inc. from 1975 to 1982.
Education includes graduate studies at Stanford University and undergraduate studies at Fort Hays State University.